Tag - PFSA

Developments

Profusa initiates first commercial revenue with healthcare research offerings launch

Profusa (NASDAQ: PFSA) has announced the launch of its healthcare research version of its Lumee tissue oxygen monitoring into the contract research organizations (CRO) market, which is expected to generate immediate...

January 16, 2026

Developments

Profusa adds leading CLTI surgeon to customer base

Profusa (NASDAQ: PFSA) has announced that Yann Gouëffic, MD, PhD, professor of vascular surgery in the Vascular Center at Groupe Hospitalier Paris Saint Joseph, Paris, France will adopt the company’s Lumee oxygen...

October 1, 2025

Tag - PFSA

Profusa initiates first commercial revenue with healthcare research offerings launch

Profusa adds leading CLTI surgeon to customer base

Subscribe